A clinical trial (also clinical research) is a research study in human volunteers to answer specific health questions. Carefully conducted clinical trials are the fastest and safest way to find treatments that are effective in human subjects. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.
Clinical trials are ongoing and some may not be listed. If you have any questions please call the CHI Health Research office at (402) 343-8511.
Study Name: CATALYST
Category: Cardiovascular
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Description: The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term NOAC therapy.
Study Name: CHAMPION-AF
Principal: Himanshu Agarwal, MD
Category: Cardiovascular
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Study Name: CHAMPION-AF
Description: The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.
Study Name: DAPA ACT HF-TIMI 68
Principal: Selma Mohammed, MD in Omaha
Anuradha Tunuguntla, MD in Lincoln
Category: Cardiovascular
Study Sites: CHI Health Clinic Heart Institute locations in Lincoln and Omaha
Description: This is an international, multicenter, parallel-group, randomized, double-blind, placebo-controlled trial in patients with heart failure with reduced ejection fraction (left ventricular ejection fraction [LVEF] ≤40%) who have been stabilized during hospitalization for acute heart failure, evaluating the effect of in-hospital initiation of dapagliflozin versus placebo on the clinical outcome of cardiovascular death or worsening heart failure.
Study Name: PROTECTED-TAVR
Principal: Himansu Agarwal, MD
Category: Cardiovascular
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Description: Stroke PROTECTion with SEntinel During Transcatheter Aortic Valve Replacement.
Study Name: STEP-HFpEF DM
Principal Investigator: Joseph Thibodeau, MD
Category: Cardiovascular
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Description: Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes
Study Name: STEP-HFpEF
Principal Investigator: Joseph Thibodeau, MD
Category: Cardiovascular
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Description: Effect of semaglutide 2.4mg once weekly on function and symptoms in subjects with obesity-related HF with HFpEF
Study Name: WARRIOR
Category: Cardiovascular
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Description: Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR).
Study Name: M14-431
Principal: Robert Kizer, MD
Category: Gastroenterology
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Description: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Biologic Therapy.
Study Name: EG-CL-101
Principal: Subhash Chandra, MD
Category: Gastroenterology
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Description: The study will assess the performance of the combined system, i.e., the use of the EsoGuard assay on cells collected using the EsoCheck 510(k) cleared device, to detect Barrett's Esophagus, with and without dysplasia, and/or Esophageal Adenocarcinoma, in individuals deemed to be at high risk for these conditions (i.e., screening) per ACG guidelines.
Study Name: EG-CL-102
Principal: Subhash Chandra, MD
Category: Gastroenterology
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Description: The study will assess the performance of the combined system, i.e., the use of the EsoGuard assay (lab developed test) on cells collected using the EsoCheck (501k cleared device) to detect Barrett's Esophagus (BE), with or without dysplasia, and esophageal adenocarcinoma (EAC) as compared to Esophagogastroduodenoscopy (EGD) plus biopsies in both confirmed cases of BE/EAC and in controls (subjects without a prior diagnosis but undergoing screening for BE/EAC)
Study Name: Blue-C
Category: Gastroenterology
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Description: The study will assess the performance of the combined system, i.e., the use of the EsoGuard assay (lab developed test) on cells collected using the EsoCheck (501k cleared device) to detect Barrett's Esophagus (BE), with or without dysplasia, and esophageal adenocarcinoma (EAC) as compared to Esophagogastroduodenoscopy (EGD) plus biopsies in both confirmed cases of BE/EAC and in controls (subjects without a prior diagnosis but undergoing screening for BE/EAC)
Study Name: NASH 747-303 REGENERATE
Principal: Sandeep Mukherjee, MD
Category: Digestive Health
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Study Name: Liver Disease Study
Description: Nonalcoholic steatohepatitis is when the liver is swollen and damaged from the build up of fat in the liver. We are investigating the safety and efficacy of an oral drug to delay health-related conditions in patients with nonalcoholic steatohepatitis or evidence of liver fibrosis (damaged or scarred liver tissue).
CHI Health participates in over 50 cancer clinical trials to find better ways to prevent, diagnose and treat cancer. Doctors use clinical trials to learn more about how to fight cancer.
Study Name: SHINE
Category: Oncology
Study Site: CHI Health Good Samaritan
Description: Optimizing Psychosocial Intervention for Breast Cancer-related Sexual Morbidity: The Sexual Health and Intimacy Education (SHINE) Trial
Study Name: Reaching Rural Cancer Survivors Who Smoke Using Text-Based Cessation Interventions
Category: Oncology
Study Site: CHI Health Good Samaritan
Study link: https://clinicaltrials.gov/study/NCT05008848
Study Name: CHRONICLE
Category: Pulmonary
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Description: A Longitudinal Prospective Observational Study of the Characteristics, Treatment Patterns and Health Outcomes of Individuals with Severe Asthma in the United States.
Study Name: GC2006
Category: Pulmonary
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Description: The purpose of the study is to determine if liquid alpha1-proteinase inhibitor (human) (liquid alpha1-PI) plus SMT can reduce the proportion of participants dying or requiring intensive care unit (ICU) admission on or before Day 29 or who are dependent on high flow oxygen devices or invasive mechanical ventilation on Day 29 versus placebo plus SMT in hospitalized participants with COVID-19.
Study Name: GD001
Principal: Michael Feloney, MD, FACS
Category: Urology
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Brief Summary: Semen Sample Collection and Processing for use in the Development of Prostate Cancer Diagnostic Tests.
A link is not available for this study.
Study Name: ACT
Principal: Michael Feloney, MD, FACS
Category: Urology
Study Site: CHI Health Creighton University Medical Center - Bergan Mercy
Brief Summary: A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.